The radiation therapy of early stage cutaneous T-cell lymphoma

Bizhan Micaily, Charles Moser, Eric C. Vonderheid, Christopher Koprowski, David Lightfoot, Arnold Markoe, Luther Brady

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (

Original languageEnglish (US)
Pages (from-to)1333-1339
Number of pages7
JournalInternational Journal of Radiation Oncology, Biology, Physics
Issue number6
StatePublished - 1990
Externally publishedYes


  • Complete response
  • Cutaneous T-cell lymphoma
  • Mechlorethamine hydrochloride
  • Total skin electron beam radiation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation


Dive into the research topics of 'The radiation therapy of early stage cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Cite this